DK516385D0 - Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter - Google Patents

Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter

Info

Publication number
DK516385D0
DK516385D0 DK516385A DK516385A DK516385D0 DK 516385 D0 DK516385 D0 DK 516385D0 DK 516385 A DK516385 A DK 516385A DK 516385 A DK516385 A DK 516385A DK 516385 D0 DK516385 D0 DK 516385D0
Authority
DK
Denmark
Prior art keywords
cell
bcel
determinants
against hepatitis
vaccine against
Prior art date
Application number
DK516385A
Other languages
Danish (da)
English (en)
Other versions
DK516385A (da
Inventor
David R Milich
Frank V Chisari
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/588,122 external-priority patent/US4599230A/en
Priority claimed from US06/587,983 external-priority patent/US4599231A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK516385A publication Critical patent/DK516385A/da
Publication of DK516385D0 publication Critical patent/DK516385D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Selective Calling Equipment (AREA)
  • Air Bags (AREA)
DK516385A 1984-03-09 1985-11-08 Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter DK516385D0 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/588,122 US4599230A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US06/587,983 US4599231A (en) 1984-03-09 1984-03-09 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
PCT/US1985/000360 WO1985004103A1 (en) 1984-03-09 1985-03-06 Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants

Publications (2)

Publication Number Publication Date
DK516385A DK516385A (da) 1985-11-08
DK516385D0 true DK516385D0 (da) 1985-11-08

Family

ID=27080174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK516385A DK516385D0 (da) 1984-03-09 1985-11-08 Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter

Country Status (11)

Country Link
EP (1) EP0155146B1 (de)
AT (1) ATE82135T1 (de)
AU (2) AU579148B2 (de)
CA (1) CA1253069A (de)
DE (1) DE3586801D1 (de)
DK (1) DK516385D0 (de)
FI (1) FI84558C (de)
IL (3) IL90035A (de)
NO (1) NO167359C (de)
NZ (2) NZ211356A (de)
WO (1) WO1985004103A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
JPH01500515A (ja) * 1986-06-20 1989-02-23 スクリップス　クリニック　アンド　リサーチ　ファウンデーション Ｂ型肝炎ウィルス表面抗原のプレｓ領域のｔ及びｂ細胞エピトープ
US6054438A (en) * 1987-01-07 2000-04-25 Imperial Cancer Research Technology Limited Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
AU1668788A (en) * 1987-05-26 1988-12-01 Wistar Institute, The Method of vaccination for hepatitis b virus
ES2167304T3 (es) * 1987-06-22 2002-05-16 Medeva Holdings Bv Peptido que contiene el antigeno de superficie de la hepatitis b.
JPH03500408A (ja) * 1987-09-04 1991-01-31 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 増強された安定性を有するペプチド複合体
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
WO1997039029A2 (en) * 1996-04-18 1997-10-23 Abbott Laboratories An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
EP2298900A1 (de) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Zusammensetzungen und Verfahren zur Behandlung intrazellulärer Erkrankungen
AU736032B2 (en) * 1996-12-30 2001-07-26 Innogenetics N.V. Annexin V-binding polypeptides derived from HBsAg and their uses
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.
DK2476436T3 (en) 2006-08-11 2018-02-05 Life Sciences Res Partners Vzw Immunogenic peptides and their use in immune disorders
CA2715611C (en) 2008-02-14 2018-03-13 Life Sciences Research Partners Vzw Immunotherapy targeting intracellular pathogens
AU2009214039B2 (en) 2008-02-14 2013-09-19 Katholieke Universiteit Leuven Immunogenic control of tumours and tumour cells
DK2643345T5 (da) 2010-11-25 2021-05-17 Imnate Sarl Immunogene peptider til anvendelse til forebyggelse og/eller behandling af infektionssygdomme, autoimmune sygdomme, immunresponser på allofaktorer, allergisygdomme, tumorer, transplantatafstødning og immunresponser på virusvektorer anvendt til genterapi eller genvaccination
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
KR101944263B1 (ko) * 2012-06-11 2019-02-01 시아먼 유니버시티 에이치비브이 감염 및 관련 질병의 치료를 위한 폴리펩타이드 및 항체
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
JP7090335B2 (ja) 2015-09-25 2022-06-24 イムサイス エスエー 治療剤に対する免疫応答を除去するための改善された方法及び化合物
WO2017182528A1 (en) 2016-04-19 2017-10-26 Imcyse Sa Novel immunogenic cd1d binding peptides
KR102358577B1 (ko) 2017-02-17 2022-02-04 시아먼 유니버시티 타겟 폴리펩티드를 제시하는 펩티드 캐리어 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
DD147855A5 (de) * 1978-12-22 1981-04-22 Biogen Nv Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
EP0082789B1 (de) * 1981-12-22 1987-04-08 Baylor College of Medicine Immunologische Zusammensetzung und Methode für Hepatitis-B-Virus
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
JPS5974985A (ja) * 1982-10-19 1984-04-27 Takeda Chem Ind Ltd 新規ｄｎａ
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids

Also Published As

Publication number Publication date
AU2682388A (en) 1989-05-25
AU579148B2 (en) 1988-11-17
WO1985004103A1 (en) 1985-09-26
NO167359C (no) 1991-10-30
FI84558B (fi) 1991-09-13
NO854460L (no) 1986-01-08
ATE82135T1 (de) 1992-11-15
CA1253069A (en) 1989-04-25
DE3586801D1 (de) 1992-12-17
NZ211356A (en) 1990-07-26
EP0155146A2 (de) 1985-09-18
EP0155146A3 (en) 1988-01-20
AU623106B2 (en) 1992-05-07
FI854396A0 (fi) 1985-11-07
IL74545A0 (en) 1985-06-30
NO167359B (no) 1991-07-22
IL90035A (en) 1990-11-05
DK516385A (da) 1985-11-08
IL74545A (en) 1990-11-05
EP0155146B1 (de) 1992-11-11
FI84558C (fi) 1991-12-27
NZ227731A (en) 1990-07-26
IL90035A0 (en) 1989-12-15
AU4115985A (en) 1985-10-11
FI854396A (fi) 1985-11-07

Similar Documents

Publication Publication Date Title
DK516385A (da) Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
ES2097878T3 (es) Fijacion de p53 sobre el adn mediante una secuencia especifica.
DE3788475D1 (de) Verwendung des Rotavirus-Nukleokapsid-VP6-Proteins in Impfstoffzusammensetzungen.
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FI863041A (fi) Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning.
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
DK235289D0 (da) Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter
DE69230671D1 (de) Impfstoffe gegen actinobacillus pleuropneumonie
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
DK0584118T3 (da) Nyt konjugat, bestående af et glycoprotein og en nucleinsyrebindende substans
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
IS3511A7 (is) Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
ES8801127A1 (es) Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna.
ES8801958A1 (es) Un procedimiento para la determinacion de virus de sida
DK381787D0 (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment